Dashboard
Portfolios
Watchlist
Community
Discover
Screener
KA
kapirey
Community Contributor
Followers
205
Total number of followers
Comments
20
Total number of comments
Member Since
2023
Date joined
Financial investor - International financial analyst - Family Office
No link added
Evolution
KA
kapirey
Community Contributor
Evolution to Navigate Market Risks with Strategic Growth Initiatives
Risks Financial risk management: market risk (including currency risk and cash flow interest risk), credit risk and liquidity risk. Political decisions and other legal aspects.
View narrative
SEK 747.99
FV
17.2% overvalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
4
users have commented on this narrative
22
users have followed this narrative
13 days ago
author updated this narrative
AB9
ABO Energy GmbH KGaA
KA
kapirey
Community Contributor
ABO Wind AG will capitalize on Europe's green transition with projected €50 million profit by 2027
1. Overview of ABO Wind AG ABO Wind AG is a German company specializing in the development of renewable energy projects, primarily wind and solar.
View narrative
€75.31
FV
47.8% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
13 days ago
author updated this narrative
Tencent Holdings
KA
kapirey
Community Contributor
Tencent Holdings will see revenue grow by 14%
Market (what, how and where Tencent sells) Business (how much Tencent earn) Catalysts. How Tencent make more money in the next 5 years Weixin Video Accounts, Mini Games and Weixin Search enhance user value by creating seamless connections with products, services and content while presenting exciting revenue opportunities.
View narrative
HK$837.52
FV
33.0% undervalued
intrinsic discount
14.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
15 days ago
author updated this narrative
BlackRock
KA
kapirey
Community Contributor
BlackRock's 5-Year Projection Shows 1391.79 Fair Value with Strong Growth Ahead
Based on the projections presented by the company on the investor day of March 31, 2025, we will assume 5-year fundamental projection for BlackRock based on its 2024 results and strategic targets: Assumptions Revenue CAGR : 10% annually, aligned with BlackRock’s 2030 ambition. Operating Margin : Maintained at 45% (as adjusted).
View narrative
US$1.39k
FV
19.2% undervalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
15 days ago
author updated this narrative
Novo Nordisk
KA
kapirey
Community Contributor
Novo Nordisk will see a 24% surge in profit margin paving way for growth
Today, July 29 Novo revised its full year 2025 guidance downward: Sales growht in local currencies now expected 8% - 14%. (down from 13% -21%.) Operating profit growth: now expected 10% -16%, ( down from 16% x24%).
View narrative
DKK 388.00
FV
16.7% undervalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
12 days ago
author updated this narrative
Neurocrine Biosciences
KA
kapirey
Community Contributor
Neurocrine Biosciences is set to achieve a 40x future PE ratio with a 17% revenue boost
Pipeline Crenessity@ CRENESSITY Capsule 50/100 MG $766.66 packaging 50 MG 60u $45,999.60 packaging 100 MG 30u. Starts at approximately $21,338.71 USD for a monthly supply Ingrezza@ Ingrezza (valbenazine) As of July 2025 , the average pharmacy acquisition cost for Ingrezza capsules in the U.S. is approximately: $274.54 per capsule for the 60 mg and 80 mg strengths $250.16 per capsule for the 40 mg strength Other Products: Tetrabenazine Tablet 12.5 MG $62.52 Austedo Tablet 6 MG $100.06 Austedo XR Tablet 6 MG $100.06 Xenazine Tablet 12.5 MG $227.88 Assumptions Risks Risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, risks and uncertainties associated with the commercialization of INGREZZA and CRENESSITY.
View narrative
US$244.80
FV
48.9% undervalued
intrinsic discount
17.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
15 days ago
author updated this narrative
IREN
KA
kapirey
Community Contributor
IREN will transform from bitcoin miner to leader in AI infrastructure
Key Highlights Financial Performance (Q3 FY25) Record Revenue : $148.1 million Record Adjusted EBITDA : $83.3 million Record EBITDA : $82.7 million Profit After Tax : $24.2 million Avg. Operating Hashrate : 29.4 EH/s Strong Margins : All-in cash cost per BTC mined at $41k vs.
View narrative
US$21.48
FV
14.1% undervalued
intrinsic discount
49.99%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
38
users have followed this narrative
15 days ago
author updated this narrative
Laboratorios Farmaceuticos Rovi
KA
kapirey
Community Contributor
The future of Rovi is very uncertain, we must wait until the year 2026 to have a clear projection.
Recent Financial Performance In H1 2025, Rovi’s net profit dropped by 10% to €39.7 million. The decline was mainly due to reduced third-party manufacturing, especially COVID-19 vaccine production.
View narrative
€51.25
FV
4.9% overvalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
15 days ago
author updated this narrative
MERLIN Properties SOCIMI
KA
kapirey
Community Contributor
Merlin Properties Will Embrace the Digital Age with Data Center Expansion
Merlin Properties: A Strategic Pivot Toward the Digital Future In 2025, Merlin Properties, one of the Iberian Peninsula’s leading real estate investment trusts (REITs), is undergoing a transformative phase. Traditionally known for its robust portfolio of offices, logistics centers, and shopping malls, Merlin has now set its sights on the digital frontier: data centers.
View narrative
€9.07
FV
46.2% overvalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 months ago
author updated this narrative